Clinical Trial Update: Prospective, Multicenter Study of the Efficacy and Tolerance of Tacrolimus on Refractory Nephrotic Syndrome (RNS) [Phase 3]

View source ↗

Summary

A Phase 3 multicenter trial evaluated the efficacy and tolerance of tacrolimus in patients with refractory nephrotic syndrome. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Kidney Diseases, Nephrotic Syndrome | Phase 3 | Status: COMPLETED